Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,910.00 6.50 (0.34%)

Bid:

1,910.00

Ask:

1,910.50

Spread: 0.50 (0.026%)

Market Cap: £76.57b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK outlook raise overshadowed by tough trade for Vaccines arm

(Alliance News) - Drugmaker GSK PLC raised its annual outlook on the back of second-quarter revenue growth, but its Vaccines offering struggled, takin...

TOP NEWS: GSK's raised outlook clouded by weak vaccines, Shingrix drop

(Alliance News) - GSK PLC on Wednesday raised its annual guidance after a strong second quarter but shares fell on a lowered outlook for its Vaccines ...

LONDON BRIEFING: GSK ups outlook; Rio Tinto at "inflection point"

(Alliance News) - London's FTSE 100 is called to open higher on Wednesday, shaking off a poor day for US tech, ahead of a Federal Reserve interest rat...

GSK lifts guidance as Q2 sales beat forecasts

(Sharecast News) - UK pharmaceutical company GSK raised annual forecasts after better-than-expected second-quarter results, driven by a strong perform...

Pfizer lifts profit forecast as investors await turnaround

July 30 (Reuters) - Pfizer raised its annual profit forecast on Tuesday, helped by cancer treatments acquired through a $43 billion deal for Seagen ...

TOP NEWS: GSK hails European opinion on Arexvy for people in their 50s

(Alliance News) - GSK PLC on Monday said its Arexvy offering received a "positive opinion" from the European Medicines Agency's Committee for Medicina...

LONDON BRIEFING: GSK's RSV jab gets Europe boost; Pearson ups payout

(Alliance News) - London's FTSE 100 is called to open higher on Monday, ahead of a trio of central bank decisions and more US earnings, including numb...

GSK says RSV jab gets EU recommendation, settles Zantac case

(Sharecast News) - GSK announced a significant development in its respiratory syncytial virus (RSV) vaccine portfolio on Monday, as well as a settleme...